Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA encoding the MAP7 protein, also known as ensconsin. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that modulate the stability and translation efficiency of the MAP7 transcript (Source: UniProt O60318). MAP7 itself is a key regulator of the microtubule cytoskeleton, functioning to stabilize microtubules and recruit kinesin-1 motors for intracellular transport (Source: PubMed: 29610382). In several malignancies, including colorectal and breast cancers, the MAP7 3'-UTR is a focal point for dysregulation; specifically, the loss of inhibitory miRNAs that normally bind this region leads to MAP7 overexpression, which promotes tumor cell invasion and metastasis (Source: PubMed: 30612335). Therapeutic approaches targeting the MAP7 mRNA 3'-UTR involve the use of miRNA mimics or antisense oligonucleotides (ASOs) designed to bind the 3'-UTR and reduce MAP7 protein levels, thereby inhibiting oncogenic progression (Source: PubMed: 31256145). As an RNA-based target, it offers a specific pathway for precision medicine in cancers where MAP7 is a driver of disease.
MicroRNA-mediated silencing or antisense oligonucleotide-induced degradation of the MAP7 mRNA transcript via sequence-specific binding to the 3'-untranslated region.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) (MAP7 mRNA 3'-UTR).